发明名称 THERAPEUTIC AGENT
摘要 <P>PROBLEM TO BE SOLVED: To provide an atypical antipsychotic which is a drug for neurological and psychiatric disorders associated with dopamine D2 and serotonin 5-HT2A neurotransmission dysfunction. <P>SOLUTION: There is provided a compound represented by formula (I) (wherein R<SP POS="POST">1</SP>is 1-6C alkyl which is unsubstituted or substituted with 1-6 fluorines and R<SP POS="POST">1</SP>and the hydroxyl group on the ring are attached to the same carbon atom). <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2013028626(A) 申请公布日期 2013.02.07
申请号 JP20120207291 申请日期 2012.09.20
申请人 MERCK SHARP & DOHME CORP 发明人 BILODEAU MARK T;NANDA KAUSIK K;TROTTER B WESLEY
分类号 A61K31/496;A61P21/00;A61P21/02;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/28;A61P43/00;C07D417/12 主分类号 A61K31/496
代理机构 代理人
主权项
地址